Trial Profile
Dosage Adjustment of Dabigatran Etexilate Based on Creatinine Clearance to avoid bleeding and stroke
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Stroke
- Focus Pharmacokinetics
- 11 Dec 2017 New trial record